Body Composition

Diminishing hormones and poor lifestyle choices alter body composition. Studies also reveal body composition changes in the aging process are multifactorial, related to concomitant changes such as hormone production, protein turnover and disuse atrophy.  Research shows hormone modulation therapy in conjunction with positive lifestyle factors can ameliorate negative body composition issues—from improved bone density to lean muscle mass and lower body fat percentile. Review current research and medical articles on body composition, discovering the relationship between bioavailable serum testosterone and estradiol and muscle strength, bone density and overall body composition.


Moderate Consumption of Olive Oil by healthy European Men Reduces Systolic Blood Pressure in Non-Mediterranean Participants.pdf

The results of this study suggest that a moderate consumption of olive oil may be used as an effective tool to reduce SBP of healthy men who do not typically consume a Mediterranean diet. However, additional longer trials are necessary for confirmation.
Bondia-Pons, I., Schroder, H., Covas, M.I., Castellote, A.I., Kaikkonen, J., Poulsen, H.E., et al. (2007). Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants [Electronic version]. The Journal of Nutrition, 137(1), 84-87. Retrieved May 14, 2007.

Aging, Adiposity, and Calorie Restriction.pdf

This study concluded that calorie restriction in adult men and women causes beneficial metabolic, hormonal, and functional changes, but the precise amount of calorie intake or body fat mass associated with optimal health and maximum longevity in humans is not known. In addition, it is possible that even moderate calorie restriction may be harmful in specific patient populations, such as lean persons who have minimal amounts of body fat.
Fontana, L. & Klein, S. (2007). Aging, adiposity, and calorie restriction [Electronic version]. The Journal of the American Medical Association, 297(9), 986-994. Retrieved May 2, 2007.

Dietary Patterns Throughout Adult Life Are Associated with Body Mass Index, Waist Circumference, Blood Pressure, and Red Cell Folate.pdf – link not working

The objective of this study was to assess the relations between dietary patterns during adult life (at ages 36, 43, and 53 y) and risk factors for chronic disease at age 53 y. Participants of a longitudinal study of health completed a 5-d food diary at 3 occasions during adult life (n = 1265). Factor analysis was used to identify dietary patterns and a pattern score was calculated from the consumption of the food items in each dietary pattern.
McNaughton, S.A., Mishra, G.D., Stephen, A.M. & Wadsworth, M.E. (2007). Dietary patterns throughout adult life are associated with body mass index, waist circumference, blood pressure, and red cell folate [Electronic version]. The Journal of Nutrition, 137(1), 99-105. Retrieved May 14, 2007.

Conjugated Linoleic Acid Supplementation for Twelve Weeks Increases Lean Body Mass in Obese Humans.pdf

In the present study, the authors performed a randomized, double-blind, placebo-controlled trial to examine the changes in body composition and clinical laboratory values following CLA (50:50 ratio of cis-9, trans-11 and trans-10, cis-12 isomers) supplementation for 12 wk in otherwise healthy obese humans. It concluded that whereas CLA may increase lean body mass in obese humans, it may also increase markers of inflammation in the short term.
Steck, S.E., Chalecki, A.M., Miller, P., Conway, J., Austin, G.L., Hardin, J.W., et al. (2007). Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans [Electronic version]. The Journal of Nutrition, 137(5), 1188-1193. Retrieved May 8, 2007.

Growth Hormone (GH) Effects on Central Fat Accumulation in Adult Japanese GH Deficient Patients: 6-Month Fixed-Dose Effects Persist During Second 6-Month Individualized-Dose Phase.pdf

This study concluded that excessively high IGF-I levels can be avoided by individualized dosing during long-term GH treatment. Individualized dosing maintains the decrease in abdominal fat in adult Japanese GHD patients and should reduce the cardiovascular risk.
Chihara, K., Shimatsu, A., Kato, Y., Kohno, H., Tanaka, T, Takano, K., et al. (2006). Growth hormone (GH) effects on central fat accumulation in adult Japanese GH deficient patients: 6-month fixed-dose effects persist during second 6-month individualized-dose phase [Electronic version]. Endocrine Journal, 53(6), 853-858. Retrieved May 14, 2007.

The Effects of Growth Hormone Therapy in HIV-Infection.pdf

The results of these studies suggested that the growth hormone might play a role in the management of visceral fat accumulation associated with HIV. Analysis of the treatment effect sizes in the published studies show that the effects of various doses of rhGH on trunk fat fit a dose-response characteristic.
Kotler, D.P. (2006). The effects of growth hormone therapy in HIV-infection [Electronic version]. American Journal of Infectious Diseases, 2(3), 153-158. Retrieved May 17, 2007.

Strength, But Not Muscle Mass, Is Associated With Mortality in the Health, Aging and Body Composition Study Cohort.pdf

This study concluded that low muscle mass did not explain the strong association of strength with mortality, demonstrating that muscle strength as a marker of muscle quality is more important than quantity in estimating mortality risk. Grip strength provided risk estimates similar to those of quadriceps strength.
Newman, A.B., Kupelian, V., Visser, M., Simonsick, E.M., Goodpaster, B.H., Kritchevsky, S.B., et al. (2006). Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort [Electronic version]. The Journals of Gerentology,
Series A, Biological Sciences and Medical Sciences, 61(1), 72-77. Retrieved May 14, 2007.

Estimates of Body Fat in Children by Hologic QDR-2000 and QDR-4500A Dual-Energy X-ray Absorptiometers Compared with Deuterium Dilution.pdf

This study evaluated the accuracy with which the Hologic QDR-4500A and QDR-2000 densitometers measure fat mass (FM) in 95 children. FM was derived from total body water measured by deuterium dilution (DD) in all children, by QDR-4500A in 50, and by QDR-2000 in 45 children.  It concluded that neither densitometer is equivalent to DD for estimation of children's FM. The QDR-4500A's current calibration seems to provide an even greater underestimate of FM than the QDR-2000.
Robotham, D.R., Schoeller, D.A., Mercado, A.B., Mirch, M.C., Theim, K.R., Reynolds, J.C., et al. (2006). Estimates of body fat in children by Hologic QDR-2000 and QDR-4500A dual-energy X-ray absorptiometers compared with deuterium dilution [Electronic version]. Journal of Pediatric Gastroenterology and Nutrition, 42(3), 331-335. Retrieved May 18, 2007.

Fountain of Youth Overflows with Hormones.pdf

According to this article, as baby boomers age, the fight against aging is being combated by increased exercise, better eating habits and the use of testosterone and other hormone replenishments.
Stetz, M. (2007, March 5). Fountain of youth overflows with hormones [Electronic version]. The San Diego Union-Tribune. Retrieved May 2, 2007.

Effect of Physical Inactivity on the Oxidation of Saturated and Monounsaturated Dietary Fatty Acids: Results of a Randomized Trial.pdf

This study concluded that independent of changes in energy balance (intake and/or output), physical inactivity decreased the oxidation of saturated but not monounsaturated dietary fat. The effect is apparently not compensated by resistance exercise training. These results suggest that Mediterranean diets should be recommended in sedentary subjects and recumbent patients.
Bergouignan, A., Schoeller, D.A., Normand, S., Gauquelin-Koch, G., Laville, M., Shriver, T., et al. (2006). Effect of physical inactivity on the oxidation of saturated and monounsaturated dietary fatty acids: results of a randomized trial [Electronic version]. PLoS Clinical Trials, 1(5), e27. Retrieved May 17, 2007.

Total Energy Expenditure in the Yakut (Sakha) of Siberia as Measured by the Doubly Labeled Water Method.pdf

This study concluded that activity levels in the Yakut were lower than those in other subsistence groups, especially the women, and were not significantly different from those in persons in industrialized nations. Persons who participated in more subsistence activities and consumed fewer market foods had significantly higher activity levels.
Snodgrass, J.J., Leonard, W.R., Tarskaia, L.A. & Schoeller, D.A. (2006). Total energy expenditure in the Yakut (Sakha) of Siberia as measured by the doubly labeled water method [Electronic version]. The American Journal of Clinical Nutrition, 84(4), 798-806. Retrieved May 17, 2007.

The Age Related Decrease in Testosterone is Significantly Exacerbated in Obese Men with the Metabolic Syndrome. What are the Implications for the Relatively High Incidence of Erectile Dysfunction Observed in These Men?.pdf

This study demonstrated that aging men with obesity and the metabolic syndrome have a significant decrease in total serum testosterone levels compared to aging, metabolically healthy men. These data suggest that the well established association between erectile dysfunction and pre-diabetes/diabetes (particularly in obese pre-diabetic/diabetic patients) may involve a hormonal component.
Kaplan, S.A., Meehan, A.G. & Shah, A. (2006). The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? [Electronic version]. The Journal of Urology, 176(4 Pt. 1), 1524-1527, discussion 1527-1528. Retrieved November 27, 2006.

What’s in a Name? Reflections on the (Suddenly) Controversial ‘Metabolic Syndrome’.pdf

According to this article, for many of us, it’s easier to think about multiple problems as having one root cause, or at least a common underlying complex pathophysiology. Hypertension, dysglycemia, dyslipidemia, and central obesity occur in the same patients more often than by chance alone.
Brieztke, S. (2006, March). What’s in a name? Reflections on the (suddenly) controversial ‘metabolic syndrome’ [Electronic version]. Endocrine Today, 4(3), 4-5. Retrieved November 16, 2006.

Risk Factors of Cardiovascular Disease in GH-Deficient Adults with Hypopituitarism: A Preliminary Report.pdf

This study concluded that an atherogenic lipid profile, insulin resistance, obesity, and increased body and trunk fat in GHD adults may cause the higher risk of cardiovascular disease in these patients. GHD adults should receive human recombinant GH along with conventional replacement therapy. This may be a useful method in protecting against early onset of atherosclerosis, metabolic disturbances, and osteoporosis, especially in young patients.
Bohdanowicz-Pawlak, A., Szymczak, J., Bladowska, J., Bednarek-Tupikowska, G., Bidzinska, B. & Milewicz, A. (2006). Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report [Electronic version]. Medical Science Monitor, 12(2), CR75-80. Epub January 26, 2006. Retrieved November 14, 2006.

High Carb, Low Glycemic Index Diet Best to Reduce CV Risk.pdf

Diets high in carbohydrates (CHOs) with low glycemic index (GI) are best for cardiovascular risk reduction, according to the results of a randomized controlled study reported in the July 24 issue of the Archives of Internal Medicine.
Barclay, L. (2006, July 25). High carb, low glycemic index diet best to reduce CV risk [Electronic version]. Medscape Medical News. Retrieved November 14, 2006.

Serum Leptin Concentrations in Pre- and Postmenopausal Women on Sex Hormone Therapy.pdf

According to this study, Endogenous E(2) and androgens in premenopausal women and estrogen and estrogen-progestin therapies in postmenopausal subjects do not influence serum leptin concentrations. Leptin level is related to body mass and BMI, but not to sex hormone status. The distribution of adipose tissue and the type of obesity (android or gynoid) have no influence on serum leptin concentration. The correlation between serum leptin level and blood pressure requires further investigation.
Bednarek-Tupikowska, G., Filus, A., Kuliczkowska-Plaksej, J., Tupikowski, K., Bohdanowicz-Pawlak, A. &  Milewicz, A. (2006). Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy. [Electronic version]. Gynecological Endocrinology, 22(4), 207-212. Retrieved November 27, 2006.

Prevalence of Hypogonadism in Males Aged at Least 45 Years: The HIM study.pdf

According to this study, based on TT concentration, the prevalence of hypogonadism in men reporting to primary care offices was estimated to be 38.7%. The medical conditions that occurred significantly more frequently among hypogonadal men than eugonadal men included increased BMI, hypertension, hyperlipidaemia, diabetes, and asthma or COPD. As men age, they are susceptible to conditions that share many of the same symptoms similar to hypogonadism. The presence of these conditions may, in effect, mask underlying hypogonadism and negatively impact quality of life.
Mulligan, T., Frick, M.F., Zuraw, Q.C., Stemhagen, A. & McWhirter, C. (2006). Prevalence of hypogonadism in males aged at least 45 years: the HIM study [Electronic version]. International Journal of Clinical Practice, 60(7), 762-769. Retrieved November 27, 2006.

DHEA in Elderly Women and DHEA or Testosterone in Elderly Men.pdf

This study concluded that neither DHEA nor low-dose testosterone replacement in elderly people has physiologically relevant beneficial effects on body composition, physical performance, insulin sensitivity, or quality of life.
Nair, K.S., Rizza, R.A., O'Brien, P., Dhatariya, K., Short, K.R., Nehra, A., et al. (2006). DHEA in elderly women and DHEA or testosterone in elderly men [Electronic version]. The New England Journal of Medicine, 355(16), 1647-1659. Retrieved November 27, 2006.

Low Serum Testosterone and Mortality in Male Veterans.pdf

This study used a clinical database to identify men older than 40 years with repeated testosterone levels obtained from October 1, 1994 to December 31, 1999, and without diagnosed prostate cancer.  It concluded that low testosterone levels were associated with increased mortality in male veterans. Further prospective studies are needed to examine the association between low testosterone levels and mortality.
Shores, M.M., Matsumoto, A.M., Sloan, K.L. & Kivlahan, D.R. (2006). Low serum testosterone and mortality in male veterans [Electronic version]. Archives of Internal Medicine, 166(15), 1660-1665. Retrieved August 28, 2006.

The Role of Conjugated Linoleic Acid in Reducing Body Fat and Preventing Holiday Weight Gain.pdf

This study concluded that conjugated linoleic acid (CLA) supplementation among overweight adults significantly reduced body fat over 6 months and prevented weight gain during the holiday season. Although no adverse effects were seen, additional studies should evaluate the effect of prolonged use of CLA.
Watras, A.C., Buchholz, A.C., Close, R.N., Zhang, Z. & Schoeller, D.A. (2006). The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain [Electronic version]. International Journal of Obesity (2005), advance online publication 2006, August 22. Retrieved November 27, 2006.

Is Leg-to-Leg BIA Valid for Predicting Minimum Weight in Wrestlers?.pdf

In this study, large individual variation was seen, and, by definition, the precision was poor when estimating MW for individuals. In practical terms, the prediction error may span multiple weight classes, thus making leg-to-leg BIA unacceptable for prediction of MW in this sample under the conditions of the study.
Clark, R.R., Bartok, C., Sullivan, J.C. & Schoeller, D.A. (2005). Is leg-to-leg BIA valid for predicting minimum weight in wrestlers? [Electronic version]. Medicine and Science in Sports and Exercise, 37(6), 1061-1068. Retrieved May 18, 2007.

Reference Body Composition in Adult Rhesus Monkeys: Glucoregulatory and Anthropometric Indices.pdf

Rhesus monkeys have been used as models to study obesity and disease. The aim of this study was to define body mass indices for underweight and obesity in rhesus monkeys. Longitudinal data collected over 8-14 years from 40 male and 26 female rhesus monkeys were analyzed.
Raman, A., Colman, R.J., Cheng, Y., Kemnitz, J.W., Baum, S.T., Weindruch, R., et al. (2005). Reference body composition in adult rhesus monkeys: glucoregulatory and anthropometric indices [Electronic version]. The Journals of Gerentology,
Series A, Biological Sciences and Medical Sciences, 60(12), 1518-1524. Retrieved May 18, 2007.

QDR 4500A Dual-Energy X-ray Absorptiometer Underestimates Fat Mass in Comparison with Criterion Methods in Adults.pdf

This study concluded that it is recommended that the lean soft tissue mass estimate with the fan-beam QDR 4500A be reduced by 5% and that for fat mass be increased by that same mass. This finding is particularly important because the National Health and Nutrition Examination Survey is using the QDR 4500A to assess body composition in a nationally representative sample of persons in the United States.
Schoeller, D.A., Tylavsky, F.A., Baer, D.J., Chumlea, W.C., Earthman, C.P., Fuerst, T., et al. (2005). QDR 4500A dual-energy X-ray absorptiometer underestimates fat mass in comparison with criterion methods in adults [Electronic version]. The American Journal of Clinical Nutrition, 81(5), 1018-1025. Retrieved May 18, 2007.

Management of Andropause: The Male Menopause.pdf

According to this article, andropause is a syndrome of physical, sexual, and psychological symptoms in aging men due to a gradual decline in serum testosterone levels. Its symptoms are more prominent in the presence of concomitant medical disorders. Testosterone replacement therapy relieves these symptoms along with improvement in bone and muscle mass, sexual function, and quality of life.
Tunuguntla, H.S.G.R. (2005, November), Management of andropause: the male menopause [Electronic version]. Clinical Geriatrics, 13(11), 27-34. Retrieved May 2, 2007.

Obesity Surgery Riskier Than Thought. Study Results Show Higher Chances of Dying Within a Year After Surgery.pdf

According to this article, obesity surgery, which is fast becoming a popular way to battle the nation’s weight crisis, may be a lot riskier than most patients realize. New research found a higher-than-expected risk of death in the year after surgery, even among young patients.
(2005, October 18). Obesity surgery riskier than thought. Study results show higher chances of dying within a year after surgery [Electronic version]. MSNBC Website. Retrieved October 26, 2005.

Effects of Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients with Ischemic Heart Disease: A Randomized Controlled Trial.pdf

In this randomized controlled trial, it was concluded that for patients with stable Ischemic Heart Disease (IHD), exercise and stress management training reduced emotional distress and improved markers of cardiovascular risk more than usual medical care alone.
Blumenthal, J.A., Sherwood, A., Babyak, M.A., Watkins, L.L., Waugh, R., Georgiades, A., et al. (2005). Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial [Electronic version]. The Journal of the American Medical Association, 293(13), 1626-1634. Retrieved May 17, 2005.

Experts Consider HT for Younger Women.pdf

Questions still persist after the release of the July 2002 Women’s Health Initiative findings regarding hormone therapy.  Researchers have been looking at the data to see if certain changes in dosage or initiation age could still provide benefits to women.
Elliott, V.S., (2005, February 28). Experts consider HT for younger women [Electronic version]. American Medical News, pp. 19-20.  Retrieved April 28, 2005.

Toward the Development of a Test for Growth Hormone (GH) Abuse: A Study of Extreme Physiological Ranges of GH-Dependent Markers in 813 Elite Athletes in the Postcompetition Setting.pdf

This study was undertaken to determine the physiological range of these GH-dependent variables in elite athletes after a competitive event to determine whether such values differ from resting values in normal and athletic subjects and to establish whether any adjustments to this range are required on the basis of age, gender, demographic characteristics, or the nature of the exercise performed.
Healy, M.L., Dall, R., Gibney, J., Bassett, E., Ehrnborg, C., Pentecost, C., et al. (2005). Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 90(2), 641-649. Epub 2004, November 16. Retrieved November 18, 2005.

Levels of Serum C-Reactive Protein During Oral and Transdermal Estradiol in Postmenopausal Women with and without a History of Intrahepatic Cholestasis of Pregnancy.pdf

This study concluded that the synthesis of CRP is not affected by a history of ICP. It is readily and dose dependently stimulated by oral but not by transdermal E2 in as soon as 2 wk.
Ropponen, A., Aittomaki, K., Tikkanen, M.J. & Ylikorkala, O. (2005). Levels of serum c-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 90(1), 142-146. Retrieved November 18, 2005.

Obesity, Weight Gain, and Risk of Biochemical Failure Among Prostate Cancer Patients Following Prostatectomy.pdf

The findings of this study validate the importance for a role of obesity in prostate cancer progression and suggest a link to the biological basis of prostate cancer progression that can be therapeutically exploited.
Strom, S.S., Wang, X., Pettaway, C.A., Logothetis, C.J., Yamamura, Y., Do, K, et al. (2005). Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy [Electronic version]. Clinical Cancer Research, 11, 6889-6894. Retrieved October 20, 2005.

Administration of Recombinant Human GHRH-1,44-Amide for 3 Months Reduces Abdominal Visceral Fat Mass and Increases Physical Performance Measures in Postmenopausal Women.pdf

This study concluded that a 3-month regimen of GHRH supplementation in postmenopausal women can stimulate GH and IGF-I production, reduce abdominal visceral fat and improve selected measures of physical performance, while inducing significant local skin reactivity.
Veldhuis, J.D., Patrie, J.M., Frick, K., Weltman, J.Y. &
Weltman, A.L. (2005). Administration of recombinant human GHRH-1,44-amide for 3 months reduces abdominal visceral fat mass and increases physical performance measures in postmenopausal women [Electronic version]. European Journal of Endocrinology, 153(5), 669-677. Retrieved January 30, 2006.

Obesity in Middle Age and Future Risk of Dementia: A 27 Year Longitudinal Population Based Study.pdf

The objective of this study was to evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life. It concluded that obesity in middle age increases the risk of future dementia independently of comorbid conditions.
Whitmer, R.A., Gunderson, E.P.,
Barrett-Connor, E., Quesenberry, C.P., Jr. & Yaffe, K. (2005). Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study [Electronic version]. BMJ (Clinical Research Ed.) 330(7504), 1360. Epub 2005, April 29. Retrieved August 17, 2006.

Study Links Fat Distribution and Not Body Weight as an Indicator of Cardiovascular Disease Risk.pdf

GE Healthcare, a unit of General Electric Company (NYSE: GE), announced that the company’s Lunar Prodigy bone density system was used in a groundbreaking study to evaluate body composition and fat distribution in the body as an important indicator of risk of cardiovascular disease.  The study was presented at the 27th Annual Meeting of the American Society for Bone and Mineral Research meeting in Nashville, TN, September 23-27.
(2005, September 23). Study links fat distribution and not body weight as an indicator of cardiovascular disease risk [Electronic version]. (PDF)

Treating Low Testosterone in Older Men Remains Controversial. Treating Hypogonadism in Older Men May Reduce Mortality, but Long-Term Data are Limited.pdf

Adrian Dobs, MD, professor of endocrinology at the Johns Hopkins University School of Medicine, spoke about low testosterone at the 87th Annual Meeting of the Endocrine Society.  Dobs said data from the Baltimore Longitudinal Study of Aging demonstrated that as many as 50% of men between the ages of 70 and 79 may have hypogonadism.
Lewis, J. (2005). Treating low testosterone in older men remains controversial. Treating hypogonadism in older men may reduce mortality, but long-term data are limited [Electronic version]. Endocrine Today, 3(8), 19. (PDF)

Hormone Replacement, the Male Version.pdf

According to this article, a growing number of men in the United States are now taking testosterone to reverse the gradual, age-related decline of the hormone, or so-called andropause. By some estimates, the number of testosterone prescriptions in the United States has tripled in recent years, and total sales now come to about $400 million a year. That’s not much compared with the $12.5 billion spent on cholesterol-lowering statins, but the upward trend is still impressive.
(2004, May). Hormone replacement, the male version [Electronic version]. Harvard Health Letter. Retrieved May 2, 2007.

Minimum Weight Prediction Methods Cross-Validated by the Four-Component Model.pdf

This study cross-validated the body composition methods of dual energy x-ray absorptiometry (DXA), leg-to-leg bioelectrical impedance analysis (BIA), hydrostatic weighing (HW), and skinfolds (SF) for predicting MW using a four-component criterion (4C). It concluded that comparable means, high correlations, regression lines that did not significantly deviate from the line of identity, and no systematic bias were found. However, the methods differed widely in precision. The best precision, based on SEE and PE values, were seen in the HW and SF methods. In conclusion, this rigorous four-component cross-validation study supports the NCAA methods as the most accurate and precise MW prediction methods in this sample.
Clark, R.R., Bartok, C., Sullivan, J.C. & Schoeller, D.A. (2004). Minimum weight prediction methods cross-validated by the four-component model [Electronic version]. Medicine and Science in Sports and Exercise, 36(4), 639-647. Retrieved May 18, 2007.

Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women's Health Initiative Randomized Controlled Trial.pdf

According to this study, the use of CEE increases the risk of stroke, decreases the risk of hip fracture, and does not affect CHD incidence in postmenopausal women with prior hysterectomy over an average of 6.8 years. A possible reduction in breast cancer risk requires further investigation. The burden of incident disease events was equivalent in the CEE and placebo groups, indicating no overall benefit. Thus, CEE should not be recommended for chronic disease prevention in postmenopausal women.
Anderson, G.L., Limacher, M., Assaf, A.R., Bassford, T., Beresford, S.A., Black, H., et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Controlled Trial [Electronic version]. The Journal of the American Medical Association, 291(14), 1701-1712. Retrieved November 21, 2005.

Safety and Adverse Effects of Androgens: How to Counsel Patients.pdf

In short-term clinical trials of androgen replacement in women, several benefits have been shown, including improved libido, bone mineral density and body composition.  While androgen therapy for women is relatively new, it is receiving more attention.
Basaria, S. & Dobs, A.S. (2004). Safety and adverse effects of androgens: how to counsel patients [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S25-32. Retrieved May 18, 2005.

Insulin-Like Growth Factor-1 as a Vascular Protective Factor.pdf

According to this study, until recently, IGF-1 was considered a mediator of vascular disease. Increasing evidence indicates, instead, that IGF-1 protects against endothelial dysfunction, atherosclerotic plaque development, the metabolic syndrome, clinical instability, and ischemic myocardial damage.
Conti, E., Carrozza, C., Capoluongo, E., Volpe, M., Crea, F., Zuppi, C., et al. (2004). Insulin-like growth factor-1 as a vascular protective factor [Electronic version]. Circulation, 110(15), 2260-2265. Retrieved May 18, 2005.

Low Testosterone Common in Type 2 Diabetes Study: 1 in 3 Diabetic Men May Suffer Low Sex Hormone Levels.pdf

A third of men with type 2 diabetes have low testosterone levels, a new study suggests.  Testosterone helps men reduce body fat and improves the way their bodies handle insulin. So low testosterone levels may have serious consequences for men with diabetes, suggests Sandeep Dhindsa, MD, of State University of New York at Buffalo.
DeNoon, D. (2004, December 1). Low testosterone common in type 2 diabetes  
study: 1 in 3 diabetic men may suffer low sex hormone levels. WebMD Health. Retrieved December 12, 2006.

The Women’s Health Initiative 2004 – Review and Critique.pdf

This article reviews the published results from the Women’s Health Initiative (WHI) and their various interpretations. The WHI was designed to define the risks and benefits of interventions, notably hormone therapy, to potentially prevent heart disease, breast and colorectal cancer, and osteoporotic fractures in postmenopausal women.
Goldman, J.A. (2004). The Women’s Health Initiative 2004 – Review and Critique [Electronic version]. Medscape General Medicine, 6(3). Retrieved September 27, 2005.

Efficacy and Tolerability of an Individualized Dosing Regimen for Adult Growth Hormone Replacement Therapy in Comparison with Fixed Body Weight-Based Dosing.pdf

This study concluded that GH replacement therapy should be initiated at a low dose and titrated to a dose producing maximal benefits without adverse side effects and an IGF-I level within the age- and sex-adjusted normal range.
Hoffman, A.R., Strasburger, C.J., Zagar, A., Blum, W.F., Kehely, A., Hartman, M.L., et al. (2004). Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 89(7), 3224-3233. Retrieved November 21, 2005.

Growth Hormone-Releasing Hormone in HIV-Infected Men with Lipodystrophy: A Randomized Controlled Trial.pdf

This study concluded that GHRH was well tolerated and effectively increased levels of IGF-1 in HIV-infected men with lipodystrophy. Total and regional body composition improved in response to GHRH, with increased lean mass and reduced truncal and visceral fat. Use of GHRH may potentially be a beneficial treatment strategy for this population.
Koutkia, P., Canavan, B., Breu, J., Torriani, M., Kissko, J. & Grinspoon, S. (2004). Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial [Electronic version]. The Journal of the American Medical Association, 292(2), 210-218. Retrieved October 11, 2005.

Review of the Book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.pdf

Review by Amazon.com of Suzanne Somers’ book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.
Lightner, J. (2004). [Review of the book The sexy years: Discover the hormone connection: the secret to fabulous sex, great health, and vitality, for women and men]. Retrieved September 10, 2004.

Adults with Partial Growth Hormone Deficiency Have an Adverse Body Composition.pdf

In summary, this study has shown that adults with Growth Hormone Insufficiency (GHI) have abnormalities of body composition characteristic of Growth Hormone Deficiency (GHD). The degree of abnormality of body composition lies between that of healthy subjects and GHD adults and correlates with the IGF-I level. Any future trials of GH replacement in patients with GHI must await further studies to establish the exact impact of this relative deficiency on the broad spectrum of biological end points influenced by GH status.
Murray, R.D., Adams, J.E. & Shalet, S.M. (2004). Adults with partial Growth Hormone deficiency have an adverse body composition [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 89(4), 1586-1591. Retrieved November 21, 2005.

Low Androgenization Index in Elderly Women and Elderly Men with Alzheimer's Disease.pdf

The authors of this study investigated whether testosterone levels and testosterone availability differ between older lean subjects with and without Alzheimer's disease (AD). Sex hormone binding globulin (SHBG) and estradiol levels were higher, whereas the free androgenization index (FAI) was lower, in lean subjects with AD than in lean subjects without AD. Factors involved in the increase of SHBG secretion could have an important role in the lower testosterone availability of subjects with AD.
Paoletti, A.M., Congia, S., Lello, S., Tedde, D., Orru, M., et al. (2004). Low androgenization index in elderly women and elderly men with Alzheimer's disease [Electronic version]. Neurology. 62(2), 301-303. Retrieved September 27, 2005.

Diet Composition and the Risk of Type 2 Diabetes: Epidemiological and Clinical Evidence.pdf

This article concludes that new emphasis on prevention by multiple lifestyle modifications, including moderate changes in the composition of the habitual diet, might limit the dramatic increase in incidence of type 2 diabetes envisaged worldwide.
Parillo, M. & Riccardi, G. (2004). Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence [Electronic version]. The British Journal of Nutrition, 92(1), 7-19. Retrieved September 27, 2005.

Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring.pdf

According to this study, hypogonadism affects an estimated 2 million to 4 million men in the United States; its prevalence increases with age. However, it has been estimated that only 5 percent of affected men currently receive treatment. Recent interest in testosterone therapy has been fueled not only by increased medical awareness of the effects of hypogonadism, but also by media attention regarding hormone-replacement therapy in both men and women, the marketing of new topical testosterone formulations, and the desire of "baby boomers" to maintain vigor and health into their more mature years.
Rhoden, E.L. & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring [Electronic version]. The New England Journal of Medicine, 350(5), 482-492. Retrieved September 27, 2005.

Long-Term Improvement of Quality of Life During Growth Hormone (GH) Replacement Therapy in Adults with GH Deficiency, as Measured by Questions on Life Satisfaction-Hypopituitarism (QLS-H).pdf

This study demonstrates that 1) improvements in QoL, as measured by the QLS-H, are maintained during long-term GH replacement therapy of adults with GHD, and 2) the QLS-H is a useful tool for evaluating QoL in hypopituitary patients treated in clinical practice. The authors suggest that evaluation of QoL should be a part of the routine clinical management of adult GH-deficient patients, complementing the measurement of surrogate biological markers or other clinical end points.
Rosilio, M., Blum, W.F., Edwards, D.J., Shavrikova, E.P., Valle, D., Lamberts, S.W., et al. (2004). Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H) [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 89(4), 1684-1693. Retrieved November 21, 2005.

Testosterone Treatment Improves Body Composition and Sexual Function in Men with COPD, in a 6-Month Randomized Controlled Trial.pdf

This article concludes that administration of a low-dose testosterone to men with COPD for 26 weeks was associated with improvement of body composition, better erectile function and sexual quality of life. Furthermore, there were no clinical or biochemical side effects.
Svartberg, J., Aasebo, U., Hjalmarsen, A., Sundsfjord, J. & Jorde, R. (2004). Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial [Electronic version]. Respiratory Medicine, 98(9), pp. 906 - 913. Retrieved September 10, 2004.

Growth Hormone Replacement Therapy Appears Safe in Long Term.pdf

Rates of death, cancers, and intracranial tumor growth do not appear to be increased by growth hormone replacement therapy in adults, Mark L. Hartman, M.D., reported at the 12th International Congress of Endocrinology.
Tucker, M.E. (2004). Growth hormone replacement therapy appears safe in long term. Family Practice News, 34(21). Retrieved May 17, 2005.

Effect of DHEA on Abdominal Fat and Insulin Action in Elderly Women and Men.pdf

This study concluded that DHEA replacement could play a role in prevention and treatment of the metabolic syndrome associated with abdominal obesity.
Villareal, D.T. & Holloszy, J.O. (2004). Effect of DHEA on abdominal fat and insulin action in elderly women and men [Electronic version]. The Journal of the American Medical Association, 292(18), 2243-2248. Retrieved November 21, 2005.

Dehydroepiandrosterone Increases Endothelial Cell Proliferation in Vitro and Improves Endothelial Function in Vivo by Mechanisms Independent of Androgen and Estrogen Receptors.pdf

The subject of this study was Dehydroepiandrosterone (DHEA).   It was examined to determine its effects on the proliferation of cultured endothelial cells, compare its effects with those of estradiol and testosterone, and examine its effects on subcellular messengers.
Williams, M.R., Dawood, T., Ling, S., Dai, A., Lew, R., Myles, K., Funder, J.W., Sudhir, K. & Komesaroff, P.A. (2004). Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors [Electronic version].  The Journal of Clinical Endocrinology and Metabolism, 89(9), 4708-4715. Retrieved May 18, 2005.

Effects of Testosterone Administration on Fat Distribution, Insulin Sensitivity, and Atherosclerosis Progression.pdf

According to this article, testosterone infusion increases coronary blood flow. Similarly, testosterone replacement retards atherogenesis in experimental models of atherosclerosis. However, the long-term risks and benefits of testosterone administration in human immunodeficiency virus-infected men with fat redistribution syndrome have not been studied in randomized clinical trials.
Bhasin, S. (2003). Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression [Electronic version]. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 37(Suppl. 2), S142-9. Retrieved September 27, 2005.

Growth Hormone Therapy in Adults.pdf

According to this review, Growth hormone (GH) is classically linked with linear growth in childhood but continues to have important metabolic actions throughout life. GH deficiency in adulthood causes a distinct syndrome with significant morbidities. These include increased total and visceral fat, decreased muscle mass and aerobic capacity, affective disturbances, abnormal lipids, and increased vascular mortality, all of which are ameliorated with GH replacement.
Cummings, D.E. & Merriam, G.R. (2003). Growth hormone therapy in adults [Electronic version]. Annual Review of Medicine, 54, 513-533. Retrieved December 7, 2005.

The Effect of Cessation of Growth Hormone (GH) Therapy on Bone Mineral Accretion in GH-Deficient Adolescents at the Completion of Linear Growth.pdf

These preliminary data suggest that, in adolescent patients with severe GHD, discontinuation of GH at completion of growth may limit the attainment of peak bone mass in this patient group. This may predispose to clinically significant osteopenia in later adult life.
Drake, W.M., Carroll, P.V., Maher, K.T., Metcalfe, K.A., Camacho-Hubner, C., Shaw, N.J., et al. (2003). The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 88(4), 1658-1663. Retrieved December 7, 2005

Testosterone and Atherosclerosis.pdf

This article concludes that the overall effect of administration of testosterone on cardiovascular-disease risk is difficult to assess because androgens have such an extraordinary array of effects in vivo.
Eckardstein, A. & Wu, F.C. (2003). Testosterone and atherosclerosis [Electronic version]. Growth Hormone & IGF Research: Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 13(Suppl. A), S72-84. Retrieved September 27, 2005.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Adults and Children -- 2003 Update.pdf

This report is based on a thorough review of published studies of the safety and efficacy of GH therapy in children and adults. Summarized herein are the indications for GH use in adults and children, the conditions for which GH use has been investigated but is not approved, and the potential adverse effects of GH therapy. The authors believe that these guidelines will help clinical endocrinologists in the treatment of patients with recombinant GH.
Gharib, H., Cook, D.M., Saenger, P.H., Bengtsson, B.A., Feld, S., et al. (2003). American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children -- 2003 update [Electronic version]. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 9(1), 64-76. Retrieved September 19, 2005.

Insulin Resistance and Prostate Cancer Risk.pdf

In this study, the associations between prostate cancer risk and insulin sensitivity or resistance were independent of total caloric intake and serum levels of insulin-like growth factors, sex hormones, and sex hormone-binding globulin. Because of the retrospective design of this study, the role of insulin resistance in prostate cancer needs to be confirmed in prospective studies.
Hsing, A.W., Gao, Y.T., Chua, S., Jr., Deng, J. & Stanczyk, F.Z. (2003). Insulin resistance and prostate cancer risk [Electronic version]. Journal of the National Cancer Institute, 95(1), 67-71. Retrieved September 27, 2005.

Effects of Growth Hormone Secretion on Body Composition in Patients with Crohn’s Disease.pdf

This study states that although serum GH levels were similar in the two groups, GH contributed significantly to the abdominal fat measurements. These data show that GH has an important role in modulating visceral fat distribution in patients with Crohn's disease.
Katznelson, L., Fairfield, W.P., Zeizafoun, N., Sands, B.E., Peppercorn, M.A., Rosenthal, D.I., et al. (2003). Effects of Growth Hormone secretion on body composition in patients with Crohn’s disease. The Journal of Clinical Endocrinology and Metabolism, 88(11), 5468-5472. Retrieved December 7, 2005.

Serum Free Testosterone in Men with Coronary Artery Atherosclerosis.pdf

The aim of this study was to determine whether levels of serum free testosterone differ between men with and without coronary artery disease. It concluded that a low level of free testosterone may be related to the development of coronary artery disease.
Sieminska, L., Wojciechowska, C., Swietochowska, E., Marek, B., Kos-Lidla, B., et al. (2003). Serum free testosterone in men with coronary artery atherosclerosis [Electronic version]. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 9(5), CR162-6. Retrieved September 27, 2005.

Five Years of Growth Hormone Replacement Therapy in Adults: Age- and Gender-Related Changes in Isometric and Isokinetic Muscle Strength.pdf

This study concluded that GH replacement therapy in adults with adult-onset GHD normalized isometric and isokinetic knee flexor and extensor strength. Hand grip strength increased but was not fully normalized.
Svensson, J., Stibrant Sunnerhagen, K. & Johannsson, G. (2003). Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 88(5), 2061-2069. Retrieved December 7, 2005.

Can Growth Hormone Prevent Aging?.pdf

This article cites the article by Rudman et al. that appeared in the Journal in 1990 that reported the effect on body composition of administering human growth hormone for six months to 12 older men. This article incited a proliferation of "antiaging" clinics and lay publications, such as "Grow Young with HGH," extolling the benefits of growth hormone in reversing or preventing aging.
Vance, M.L. (2003). Can growth hormone prevent aging? [Electronic version]. The New England Journal of Medicine, 348(9), 779-780. Retrieved October 31, 2005.

Recombinant Human Growth Hormone Treatment in Elderly Patients Undergoing Elective Total Hip Replacement.pdf

This study concluded that in elderly patients undergoing total hip replacement, preoperative GH treatment results in improvements in lean body mass and skeletal muscle mass that are sufficient to offset postoperative losses.  The treatment may also preserve or improve muscle strength and postoperative walking ability.
Weissberger, A.J., Anastasiadis, A.D., Sturgess, I., Martin, F.C., Smith, M.A. & Sonksen, P.H. (2003). Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement [Electronic version]. Clinical Endocrinology (Oxford), 58(1), 99-107. Retrieved May 17, 2005.

Single and Combined Effects of Growth Hormone and Testosterone Administration on Measures of Body Composition, Physical Performance, Mood, Sexual Function, Bone Turnover, and Muscle Gene Expression in Healthy Older Men.pdf

This study examined the effects of GH and/or testosterone (T) administration on body composition, performance, mood, sexual function, bone turnover, and muscle-gene expression in healthy older men.  It concluded that 1 month of GH and/or T administration improves certain measures of balance and physical performance in older men and increases muscle IGF-I gene expression.
Brill, K.T., Weltman, A.L., Gentili, A., Patrie, J.T., Fryburg, D.A., Hanks, J.B., et al. (2002). Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 87(12), 5649-5657. Retrieved January 4, 2006.

Human Growth Hormone Replacement in Adult Hypopituitary Patients: Long-Term Effects on Body Composition and Lipid Status--3-Year Results from the HypoCCS Database.pdf

Observational data confirm some important aspects of diagnosis of the adult GHD syndrome and of efficacy and safety of GH replacement.  Specifically, GH replacement therapy of GHD patients in HypoCCS induced significant long-term efficacy in terms of body composition and lipid profiles.
Attanasio, A.F., Bates, P.C., Ho, K.K., Webb, S.M., Ross, R.J., Strasburger, C.J., et al. (2002). Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 87(4), 1600-1606. Retrieved January 19, 2005.

Inverse Relationship Between Total Testosterone and Anti-Oxidized Low Density Lipoprotein Antibody Levels in Ageing Males.pdf

This study showed that in multiple regression analysis only testosterone level was independently associated with anti-oxLDL Ab. These data suggest a that fall of testosterone concentration in ageing men can influence either oxidative modification of LDL or the immune response to these lipoproteins which may be important in the pathogenesis of atherosclerosis.
Barud, W., Palusinski, R.,Beltowski, J. & Wojcicka, G. (2002). Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males [Electronic version]. Atherosclerosis, 164(2), 283-288. Retrieved September 27, 2005.

Familial Isolated Growth Hormone Deficiency is Associated with Increased Systolic Blood Pressure, Central Obesity, and Dyslipidemia.pdf

The conclusion of this study was that this genetically homogeneous isolated GHD population presents a syndrome characterized by central obesity, dyslipidemia, and elevated SBP but reduced cardiac dimensions compared with controls.
Barreto-Filho, J.A., Alcantara, M.R., Salvatori, R., Barreto, M.A., Sousa, A.C., Bastos, V., et al. (2002). Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 87(5), 2018-2023. Retrieved December 7, 2005.

Severely Burned Patients After Surgery: Recombinant Human Growth Hormone Therapy its Metabolic Effects.pdf

This study concludes that recombinant human growth hormone (rhGH) has a beneficial effect on metabolism in patients who are severely burned.  Hyperglycemia, however, is apt to occur and water, Na(+), Cl(-) retention are suggested.  Fifty patients were studied.
Chai, J., Hao, D., Wu, Y., Shen, C., Guo, Z. & Sheng, Z. (2002). [Severely burned patients after surgery: recombinant human growth hormone therapy its metabolic effects] [Article in Chinese] [Electronic version]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery], 40(2), 107-111. Retrieved May 18, 2005.

The Cardiovascular Risk of Adult GH Deficiency (GHD) Improved After GH Replacement and Worsened in Untreated GHD: A 12-Month Prospective Study.pdf

This study concluded that 12 months of GH replacement normalized IGF-I and improved lipid profile and cardiac performance in adult GHD patients. A similar period of GH deprivation induced a further impairment of lipid profile and cardiac performance. This finding strongly supports the need of GH replacement in adult GHD patients.
Colao, A., di Somma, C., Pivonello, R., Cuocolo, A., Spinelli, L., et al. (2002).  The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 87(3), 1088-1093. Retrieved September 26, 2005.

Hormone Replacement Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women.pdf

The authors concluded that postmenopausal women taking oral estrogen or those taking a combination of estrogen and HRT are more insulin-resistant than women not on HRT, even when women are of comparable total and abdominal adiposity.
Ryan, A.S., Nicklas, B.J. & Berman, D.M. (2002). Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women [Electronic version]. Diabetes Care, 25(1), 127-133. Retrieved January 19, 2006.

Effect of Recombinant Human Growth Hormone in the Treatment of Visceral Fat Accumulation in HIV Infection.pdf

In conclusion, this study found that rhGH effectively reduces the excess visceral adipose tissue often associated with HIV fat redistribution/lipodystrophy. However, frequent adverse effects warrant controlled studies and careful patient monitoring, especially regarding glucose tolerance.
Engelson, E.S., Glesby, M.J., Mendez, D., Albu, J.B., Wang, J., Heymsfield, S.B., et al. (2002). Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection [Electronic version]. Journal of Acquired Immune Deficiency Syndromes, 30(4), 379-391. Retrieved December 7, 2005.

Growth Hormone Therapy for Adults: Not Ready for Prime Time?.pdf

This article states that long-term studies in patients receiving appropriate comprehensive management for other hormonal deficiencies and for concomitant abnormalities will be required to convince physicians of the utility and safety of growth hormone replacement therapy.
Isley, W.L. (2002). Growth hormone therapy for adults: not ready for prime time? [Electronic version]. Annals of Internal Medicine, 137(3), 190-196. Retrieved September 26, 2005.

Changes in Body Composition During Androgen Deprivation Therapy for Prostate Cancer.pdf

The aim of this study was to determine the effects of initial treatment with a GnRH agonist on body composition in asymptomatic men with nonmetastatic prostate cancer. 
Smith, M.R., Finkelstein, J.S., McGovern, F.J., Zietman, A.L., Fallon, M.A., Schoenfeld, D.A., et al. (2002). Changes in body composition during androgen deprivation therapy for prostate cancer [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 87(2), 599-603. Retrieved December 7, 2005.

Exercise Type and Intensity in Relation to Coronary Heart Disease in Men.pdf

This study concluded that total physical activity, running, weight training, and walking were each associated with reduced CHD risk. Average exercise intensity was associated with reduced risk independent of the number of MET-hours spent in physical activity.
Tanasescu, M., Leitzmann, M.F., Rimm, E.B., Willett, W.C., Stampfer, M.J. & Hu, F.B. (2002). Exercise type and intensity in relation to coronary heart disease in men [Electronic version]. The Journal of the American Medical Association, 288(16), 1994-2000. Retrieved September 27, 2005.

Body Composition and Quality of Life in Adults with Growth Hormone Deficiency; Effects of Low-Dose Growth Hormone Replacement.pdf

This study discusses how low-dose GHR improves body composition and QoL as early as 1 month after commencement and the beneficial effects continue at 3 months. Most importantly, these changes occur in the absence of side-effects.
Ahmad, A.M., Hopkins, M.T., Thomas, J., Ibrahim, H., Fraser, W.D., et al. (2001). Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement [Electronic version]. Clinical Endocrinology (Oxford), 54(6), 709-717. Retrieved September 14, 2005.

Association of IGF-I Levels with Muscle Strength and Mobility in Older Women.pdf

This article summarizes that in a study population including frail and healthy older women, low IGF-I levels were associated with poor knee extensor muscle strength, slow walking speed, and self-reported difficulty with mobility tasks. These findings suggest a role for IGF-I in disability as well as a potential target population for interventions to raise IGF-I levels.
Cappola, A.R., Bandeen-Roche, K., Wand, G.S., Volpato, S. & Fried, L.P. (2001). Association of IGF-I levels with muscle strength and mobility in older women [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 86(9), 4139-4146. Retrieved September 28, 2005.

Low-Dose Growth Hormone Treatment Combined with Diet Restriction Decreases Insulin Resistance by Reducing Visceral Fat and Increasing Muscle Mass in Obese Type 2 Diabetic Patients.pdf

This study concluded that low-dose GH treatment combined with dietary restriction resulted not only in a decrease of visceral fat but also in an increase of muscle mass with a consequent improvement of the insulin resistance observed in obese type 2 diabetic patients.
Nam, S.Y., Kim, K.R., Cha, B.S., Song, Y.D., Lim, S.K., Lee, H.C., et al. (2001). Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients [Electronic version].  International Journal of Obesity and Related Metabolic Disorders, 25(8), 1101-1107. Retrieved January 19, 2006.

Personal Business; Trying to Roll Back the Biological Clock, for a Price.pdf

This article, written soon after September 11th, says that Americans have been re-evaluating their priorities since the attacks, and for some people that means paying closer attention to their health. There has even been a rise in interest in so-called anti-aging clinics.  It discusses several clinics, including Cenegenics.
Siwolop, S. (2001, October 21). Personal business; trying to roll back the biological clock, for a price [Electronic version]. The New York Times. Retrieved October 31, 2005.

Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men. Testosterone Gel Study Group.pdf

This study concluded that T gel replacement improved sexual function and mood, increased lean mass and muscle strength (principally in the legs), and decreased fat mass in hypogonadal men with less skin irritation and discontinuation compared with the recommended dose of the permeation-enhanced T patch.
Wang, C., Swedloff, R.S., Iranmanesh, A., Dobs, A., Snyder, P.J., Cunningham, G., et al. (2000). Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone gel study group [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 85(8), 2839-2853. Retrieved July 19, 2003.

Growth Hormone Replacement in Adults with Growth Hormone Deficiency: Assessment of Current Knowledge.pdf

This article states that recent availability of recombinant human growth hormone (GH) has led to intense investigation of the consequences of adult GH deficiency (GHD) and the effects of GH replacement. These studies have led to the identification of a characteristic syndrome of GHD consisting of decreased mood and well-being, with alterations in body composition and substrate metabolism.
Carroll, P.V., Christ, E.R. & Sonksen, P.H. (2000). Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge [Electronic version]. Trends in Endocrinology and Metabolism, 11(6), 231-238. Retrieved January 18, 2006.

Effects of 7 Years of Growth Hormone Replacement Therapy in Hypopituitary Adults.pdf

This study concludes that prolonged GH substitution in middle-aged hypopituitary adults causes a sustained improvement in body composition. Other benefits, e.g. on lipid levels and exercise tolerance, were not apparent at 7 yr when comparisons were made with GH-untreated hypopituitary controls. Potentially adverse effects on glucose tolerance and insulinemia did not develop with prolonged GH therapy.
Chrisoulidou, A., Beshyah, S.A., Rutherford, O., Spinks, T.J., Mayet, J., et al. (2000). Effects of 7 years of growth hormone replacement therapy in hypopituitary adults [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 85(10), 3762-3769. Retrieved September 14, 2005.

Testosterone Therapy in Men: An Update.pdf

This article discusses that because testosterone levels decline with age, and aging is accompanied by body changes including loss of muscle and increases in fat, there is great interest in the potential benefits of testosterone administration in elderly men.
Katznelson, L. (2000, Winter). Testosterone therapy in men: an update [Electronic version]. MGH Neuroendocrine Clinical Center Newsletter Bulletin, 6(2). Retrieved September 14, 2005.

Serum Lipid and Leptin Concentrations in Hypopituitary Patients with Growth Hormone Deficiency.pdf

The conclusion of this study was that growth hormone deficient hypopituitary patients (particularly women) on conventional replacement therapy have a more atherogenic lipid profile. Leptin concentrations are increased in GH deficient adults even after adjustment for percentage body fat and body fat mass (kg).
Ozbey, N., Algun, E., Turgut, A.S., Orhan, Y., Sencer, E. & Molvalilar, S. (2000). Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency [Electronic version]. International Journal of Obesity and Related Metabolic Disorders, 24(5), 619-626. Retrieved January 19, 2006.

Aerobic Exercise Training-Induced Reductions in Abdominal Fat and Glucose-Stimulated Insulin Responses in Middle-Aged and Older Men.pdf

According to this study, the decrease in glucose-stimulated insulin secretion with aerobic exercise training in middle-aged and older men appears to be mediated, at least in part, by reductions in the amount of abdominal fat. Regular physical exercise may prevent or ameliorate conditions associated with hyperinsulinemia including dyslipidemia, hypertension, and atherosclerosis in this group.
Pratley, R.E., Hagberg, J.M., Dengel, D.R., Rogus, E.M., Muller, D.C., et al. (2000). Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulated insulin responses in middle-aged and older men [Electronic version]. Journal of the American Geriatrics Society, 48(9), 1055-1061. Retrieved September 14, 2005.

Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency. A Randomized, Controlled Clinical Trial.pdf

This study concludes that long-term growth hormone replacement in men reduces levels of inflammatory cardiovascular risk markers, decreases central fat, and increases lipoprotein(a) and glucose levels without affecting lipid levels.
Sesmilo, G., Biller, B.M., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., et al. (2000). Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial [Electronic version]. Annals of Internal Medicine, 133(2), 111-122. Retrieved January 18, 2006.

Measures of Bioavailable Serum Testosterone and Estradiol and Their Relationships with Muscle Strength, Bone Density, and Body Composition in Elderly Men.pdf

In this cross-sectional study in healthy elderly men, non-SHBG-bound T seems to be the best parameter for serum levels of bioactive T, which seems to play a direct role in the various physiological changes that occur during aging. A positive relation with muscle strength and BMD and a negative relation with fat mass was found. In addition, both serum E1 and E2 seem to play a role in the age-related bone loss in elderly men, although the cross-sectional nature of the study precludes a definitive conclusion. Non-SHBG-bound E2 seems to be the best parameter of serum bioactive E2 in describing its positive relation with BMD.
van den Beld, A.W., de Jong, F.H., Grobbee, D.E., Pols, H.A. & Lamberts, S.W. (2000). Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 85(9), 3276-3282. Retrieved October 3, 2005.

Nutritional, Respiratory, and Psychological Effects of Recombinant Human Growth Hormone in Patients Undergoing Abdominal Aortic Aneurysm Repair.pdf

This pilot study indicates that rhGH administered preoperatively has beneficial effects on skeletal muscle and respiratory function and may be more useful than postoperative rhGH administration alone.
Barry, M.C., Mealy, K., O'Neill, S., Hughes, A., McGee, H., Sheehan, S.J., et al. (1999). Nutritional, respiratory, and psychological effects of recombinant human growth hormone in patients undergoing abdominal aortic aneurysm repair [Electronic version]. Journal of Parenteral and Enteral Nutrition, 23(3), 128-135. Retrieved January 4, 2006.

Risks Versus Benefits of Testosterone Therapy in Elderly Men.pdf

This review discusses the pros and cons of testosterone replacement in hypogonadal elderly men and attempts to answer some of the unanswered questions. Furthermore, emphasis is made on the regular follow-up of these patients to prevent the development of therapy-related complications.
Basaria, S. & Dobs, A.S. (1999). Risks versus benefits of testosterone therapy in elderly men [Electronic version]. Drugs & Aging, 15(2), 131-142. Retrieved September 14, 2005.

Effect of Oral DHEA on Serum Testosterone and Adaptations to Resistance Training in Young Men.pdf

This study examined the effects of acute dehydroepiandrosterone (DHEA) ingestion on serum steroid hormones and the effect of chronic DHEA intake on the adaptations to resistance training. These results suggest that DHEA ingestion does not enhance serum testosterone concentrations or adaptations associated with resistance training in young men.
Brown, G.A., Vukovich, M.D., Sharp, R.L., Reifenrath, T.A., Parsons, K.A., et al. (1999). Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men [Electronic version]. Journal of Applied Physiology, 87(6), 2274-2283. Retrieved September 14, 2005.

The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients.pdf

This study concluded that GH treatment for 10 yr in GHD adults resulted in increased lean body and muscle mass, a less atherogenic lipid profile, reduced carotid intima media thickness, and improved psychological well-being.
Gibney, J., Wallace, J.D., Spinks, T., Schnorr, L., Ranicar, A., Cuneo, R.C., et al. (1999). The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 84(8), 2596-2602. Retrieved January 25, 2006.

Long-Term Effects of Growth Hormone Therapy on Intermediary Metabolism and Insulin Sensitivity in Hypopituitary Adults.pdf

This study found that the available evidence suggests that concerns regarding glucose intolerance in patients receiving long-term GH therapy have not been substantiated. The beneficial effects on body composition, and on total and low density lipoprotein cholesterol levels, persisted over the 4 years of study.
Johnston, D.G., Al-Shoumer, K.A.,